5-HydroxydecanOATe sodium 是一种选择性 ATP 敏感的 K+ (KATP) 通道阻滞剂 (IC50 约为 30 μM)。5-HydroxydecanOATe sodium 是线粒体外膜酰基辅酶 A 合成酶的底物，并具有抗氧化活性。

5-Hydroxydecanoate sodium is a selective ATP-sensitive K+ (KATP) channel blocker (IC50 of ~30 μM). 5-Hydroxydecanoate sodium is a substrate for mitochondrial outer membrane acyl-CoA synthetase and has antioxidant activity.

5-Hydroxydecanoate (5-HD) treatment abolishs the beneficial effects of penehyclidine hydrochloride (PHC) preconditioning in anoxia/reoxygenation (A/R)‐induced injury in H9c2 cells. 5-Hydroxydecanoate blocks the inhibitory effect of PHC on Ca2+ overload and ROS production. 5-Hydroxydecanoate promotes the release of Cyt-C from mitochondria into cytoplasm. 5-Hydroxydecanoate attenuats the anti-apoptotic effect of PHC. PHC treatment shows remarkably decreases levels of Bax and cleaved caspase-3, and increases levels of Bcl-2. 5-Hydroxydecanoate pretreatment reverses the effects of PHC on their expression levels. 5-Hydroxydecanoate blocks the effects of PHC on KATP channels[1].

5-Hydroxydecanoate (100 μM) treatment abolishes the effects of ischemic preconditioning (IPC) on the contractile recovery and does not affect its effect on the contracture, lactate production, glycogenolysis and viable tissue in rats[3].

71186-53-3

C10H19NaO3

210.25

Sodium 5-hydroxydecanoate

H2O:8mg/mL(38.05mM),Need ultrasonic
DMSO:11.7mg/mL (55.6mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years